| Name | KT185 |
|---|
| Description | KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC50 0.21 nM in Neuro2A cells[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: ABHD6 (0.21 nM in Neuro2A cells)[1]. |
| References |
| Molecular Formula | C32H33N5O2 |
|---|---|
| Molecular Weight | 519.64 |
| RIDADR | NONH for all modes of transport |
|---|